title: Drug Combo Adds No Benefit in Patients with Type 2 Diabetes.
authors.affiliation: Billings, MT, USA.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Geurin
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D018819:Dipeptidyl Peptidase 4 / Q000187:drug effects* / Q000378:metabolism; D004359:Drug Therapy, Combination; D000067757:Glucagon-Like Peptide-1 Receptor / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000069450:Liraglutide / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate / Q000627:therapeutic use*; D000097789:Glucagon-Like Peptide-1 Receptor Agonists
chemical_list: D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D000069450:Liraglutide; D008687:Metformin; C042807:DPP4 protein, human; D018819:Dipeptidyl Peptidase 4; D000068900:Sitagliptin Phosphate; D000097789:Glucagon-Like Peptide-1 Receptor Agonists